Clinical Trial Update: Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from Assiut University is evaluating the efficacy and cost-effectiveness of topical vancomycin powder to prevent ventriculoperitoneal s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hydrocephalus
• Ventriculoperitoneal Shunt Infection

Drugs mentioned

• Vancomycin powder (topical) (vancomycin powder)

Snippet

Sponsor: Assiut University | Conditions: Hydrocephalus, Ventriculoperitoneal Shunt Infection | Phase 4 | Status: NOT_YET_RECRUITING